Klisovic, R. B., Blum, W., Wei, X., Liu, S., Liu, Z., Xie, Z., . . . Marcucci, G. (2008). Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase, in Combination with High-Dose Cytarabine in Patients with Acute Myeloid Leukemia.
استشهاد بنمط شيكاغوKlisovic, Rebecca B., et al. Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase, in Combination With High-Dose Cytarabine in Patients With Acute Myeloid Leukemia. 2008.
MLA استشهادKlisovic, Rebecca B., et al. Phase I Study of GTI-2040, an Antisense to Ribonucleotide Reductase, in Combination With High-Dose Cytarabine in Patients With Acute Myeloid Leukemia. 2008.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.